About
Technology
Issues
FAQ
Links
Official Page
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.